Latest Breaking News On - Company nati - Page 1 : comparemela.com

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

Inventiva intends to use the proceeds to fund part of its ongoing pivotal NATiV3 Phase III clinical trial evaluating lanifibranor in patients with.

United statesNew yorkPascaline clercJean volatierAude lepreuxExchange commission onEuropean investment bankPatricial bankCompany natiBrunswick groupCorporate affairsLong island cityEuronext parisFinance contractDeputy chief executive officerChief financial officer

INVENTIVA: Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

INVENTIVA: Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkPascaline clercAude lepreuxJean volatierCorporate affairsExchange commission onCompany natiPatricial bankBrunswick groupEuropean investment bankLong island cityEuronext parisFinance contractDeputy chief executive officerChief financial officer

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkAude lepreuxPascaline clercJean volatierPatricial bankCompany natiBrunswick groupCorporate affairsExchange commission onEuropean investment bankLong island cityEuronext parisFinance contractDeputy chief executive officerChief financial officer

INVENTIVA: Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program

INVENTIVA: Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAude lepreuxStefan klotterSino biopharmPascaline clercEuropean investment bankChina national medical products administrationCompany natiEuropean medicines agencyExchange commission onEuropean unionCorporate affairsChia tai tianqing pharmaceutical group co ltdPatricial bankData monitoring committee

Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program

Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United statesNew yorkPascaline clercAude lepreuxSino biopharmEuropean investment bankChia tai tianqing pharmaceutical group co ltdCorporate affairsEuropean unionData monitoring committeeCompany natiChina national medical products administrationPatricial bankExchange commission onDrug administrationEuropean medicines agency